In line with previous studies, the mRNA expression of SREBP-1c was significantly increased in NAFLD rats; however, it was downregulated by HXQYF (45 mg/kg), accompanied by the decrease of lipid accumulation in the liver. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.